IL137479A - Peroral active agent suspension - Google Patents

Peroral active agent suspension

Info

Publication number
IL137479A
IL137479A IL13747999A IL13747999A IL137479A IL 137479 A IL137479 A IL 137479A IL 13747999 A IL13747999 A IL 13747999A IL 13747999 A IL13747999 A IL 13747999A IL 137479 A IL137479 A IL 137479A
Authority
IL
Israel
Prior art keywords
active agent
agent suspension
peroral
peroral active
suspension
Prior art date
Application number
IL13747999A
Other versions
IL137479A0 (en
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of IL137479A0 publication Critical patent/IL137479A0/en
Publication of IL137479A publication Critical patent/IL137479A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
IL13747999A 1998-03-27 1999-03-23 Peroral active agent suspension IL137479A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98105568A EP0945131A1 (en) 1998-03-27 1998-03-27 Peroral drug suspension
PCT/EP1999/001948 WO1999049845A1 (en) 1998-03-27 1999-03-23 Peroral active agent suspension

Publications (2)

Publication Number Publication Date
IL137479A0 IL137479A0 (en) 2001-07-24
IL137479A true IL137479A (en) 2005-09-25

Family

ID=8231651

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13747999A IL137479A (en) 1998-03-27 1999-03-23 Peroral active agent suspension

Country Status (26)

Country Link
EP (2) EP0945131A1 (en)
JP (1) JP3323189B2 (en)
KR (1) KR100587208B1 (en)
CN (1) CN1150888C (en)
AR (1) AR016196A1 (en)
AT (1) ATE225648T1 (en)
AU (1) AU762464B2 (en)
BR (1) BR9909189A (en)
CA (1) CA2326048C (en)
CO (1) CO5070601A1 (en)
DE (1) DE59903023D1 (en)
DK (1) DK1066029T3 (en)
ES (1) ES2184428T3 (en)
HK (1) HK1034184A1 (en)
HU (1) HU228474B1 (en)
IL (1) IL137479A (en)
MY (1) MY124599A (en)
NO (1) NO321401B1 (en)
NZ (1) NZ507610A (en)
PL (1) PL192969B1 (en)
PT (1) PT1066029E (en)
TR (1) TR200002772T2 (en)
TW (1) TWI232759B (en)
UY (1) UY25443A1 (en)
WO (1) WO1999049845A1 (en)
ZA (1) ZA200003951B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8231899B2 (en) 1998-09-10 2012-07-31 Nycomed Danmark Aps Quick release pharmaceutical compositions of drug substances
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (en) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Highly concentrated stable meloxicam solutions for needleless injection
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
EP1938803A3 (en) * 2003-03-03 2010-10-27 Elan Pharma International Limited Formulations comprising nanoparticulate meloxican
US20100297252A1 (en) 2003-03-03 2010-11-25 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations
AU2003100262B4 (en) * 2003-04-07 2003-09-18 Jurox Pty Ltd Stable carprofen composition
US20050158367A1 (en) * 2004-01-16 2005-07-21 The Procter & Gamble Company Liquid compositions comprising one or more medicaments
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
WO2006042381A1 (en) * 2004-10-21 2006-04-27 Parnell Laboratories (Aust) Pty Limited Anti-inflammatory preparation
EP1824493B1 (en) * 2004-12-06 2008-08-13 Janssen Pharmaceutica N.V. Oral suspension comprising meloxicam
GB2438287A (en) 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
CN102647971B (en) 2009-10-12 2016-03-16 贝林格尔.英格海姆维特梅迪卡有限公司 For comprising the container of the compositions of meloxicam
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
WO2011107150A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
JP6092629B2 (en) * 2010-03-10 2017-03-08 ルピン・リミテッドLupin Limited Suspension prepared for use with rifaximin
RU2015142279A (en) * 2010-03-19 2018-12-28 Бостон Байомедикал, Инк. NEW COMPOUNDS AND COMPOSITIONS FOR TARGETING MALIGNANT STEM CELLS
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
GB201117858D0 (en) 2011-10-17 2011-11-30 Norbrook Lab Ltd Paste
EP2937640A4 (en) * 2012-12-19 2016-08-17 Mitsubishi Electric Corp Air conditioner
MX2017013715A (en) 2015-04-28 2018-03-02 Mars Inc Process of preparing a sterilized wet pet food product.
KR102145022B1 (en) * 2018-08-14 2020-08-14 동아제약 주식회사 Suspension composition and dosage form of ibuprofen
CN112044605B (en) * 2019-06-06 2022-06-21 钟志勇 Titanium selection medicament and titanium selection method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196307B (en) * 1984-10-22 1988-11-16 Chiesi Farma Spa AQUEOUS PHARMACEUTICAL FORMULATIONS OF PIROXICAM MONOHYDRATE
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
JP2860729B2 (en) * 1992-03-10 1999-02-24 エスエス製薬株式会社 Planoprofen suspension syrup
GB2318511A (en) * 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water

Also Published As

Publication number Publication date
ATE225648T1 (en) 2002-10-15
UY25443A1 (en) 1999-11-17
NZ507610A (en) 2003-08-29
NO321401B1 (en) 2006-05-08
ES2184428T3 (en) 2003-04-01
PL342345A1 (en) 2001-06-04
PT1066029E (en) 2003-02-28
PL192969B1 (en) 2006-12-29
TR200002772T2 (en) 2000-12-21
JP3323189B2 (en) 2002-09-09
MY124599A (en) 2006-06-30
KR20010042197A (en) 2001-05-25
DK1066029T3 (en) 2003-01-27
KR100587208B1 (en) 2006-06-08
HUP0102036A3 (en) 2002-12-28
EP1066029A1 (en) 2001-01-10
AU762464B2 (en) 2003-06-26
IL137479A0 (en) 2001-07-24
HUP0102036A2 (en) 2002-03-28
CA2326048C (en) 2008-08-12
BR9909189A (en) 2000-12-05
AR016196A1 (en) 2001-06-20
ZA200003951B (en) 2002-01-18
JP2002509875A (en) 2002-04-02
CN1150888C (en) 2004-05-26
CA2326048A1 (en) 1999-10-07
DE59903023D1 (en) 2002-11-14
CN1295462A (en) 2001-05-16
WO1999049845A1 (en) 1999-10-07
EP0945131A1 (en) 1999-09-29
CO5070601A1 (en) 2001-08-28
NO20004822D0 (en) 2000-09-26
AU3147099A (en) 1999-10-18
NO20004822L (en) 2000-11-23
HK1034184A1 (en) 2001-10-19
HU228474B1 (en) 2013-03-28
EP1066029B1 (en) 2002-10-09
TWI232759B (en) 2005-05-21

Similar Documents

Publication Publication Date Title
IL137479A0 (en) Peroral active agent suspension
AU1433299A (en) Disinfecting agent
AP2000001869A0 (en) Pharmaceutically active morpholinol
EP1017770A4 (en) Aqueous rinsing composition
EG22674A (en) Ectroparasiticidal aquequs suspension formulations
GB9906447D0 (en) Suspension arrangements
EP1008352A4 (en) Brain-protective agent
HK1047241A1 (en) Radioprotecting agent
IL147680A (en) Antistatic agent
GB9827075D0 (en) Novel active headset
ZA987483B (en) Contrast agent
IL121396A0 (en) Stabilizer
GB2338498B (en) Suspension arrangement
EP1157700A4 (en) Anti-hiv agent
GB9930484D0 (en) Resilient bush
GB9827088D0 (en) Silylating agent
PL324932A1 (en) Mould-killing agent
MD823F1 (en) Antimutagenous agent
PL318517A1 (en) Disinfecting agent
GB9929736D0 (en) Suspension point
AU136370S (en) Handkerchief
AU136114S (en) Handkerchief
GB9805101D0 (en) Earplug
ZA991336B (en) Odoriferous agent.
GB9827795D0 (en) Permanent suspension point

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired